常盤薬品工業 announced that it had renewed the brand of its Nameraka Honpo skincare series, with cumulative sales reaching 270 million units. Against a backdrop of growth for 4 consecutive years, the company said it would pursue a new design and strengthen the brand's appeal.
常盤薬品工業 announced that it had renewed the brand of its long-selling Nameraka Honpo skincare series. The announcement indicates an intention to sustain the series' growth through a brand redesign and stronger marketing appeal.
The company reported that cumulative sales of the Nameraka Honpo skincare series had reached 270 million units. Although no specific timing was provided, the renewal appears to be based on the series' long-term sales performance.
The article refers to "4 consecutive years of growth," indicating that the brand renewal is positioned as a means of sustaining growth. It also references J-Beauty, suggesting an approach that takes trends in the domestic and overseas beauty products markets into account.
Going forward, attention is expected to focus on sales trends following the renewal, market acceptance of the new design, and the rollout of promotional initiatives. As of now, no additional specific figures or timing have been confirmed.